Changes in placental angiogenesis and their correlation with foetal intrauterine restriction

Ceska Gynekologie
|May 7, 2015
PubMed

Insights

Intrauterine growth restriction (IUGR) affects 3-10% of pregnancies. This review examines how placental vascular development changes impact fetal growth, focusing on angiogenesis in IUGR.

Area of Science:

  • Obstetrics and Gynecology
  • Fetal Medicine
  • Reproductive Biology

Background:

  • Intrauterine growth restriction (IUGR) affects 3-10% of pregnancies, often defined by fetal weight below the 10th percentile.
  • Pathological interference with placental vascular development critically impacts fetal growth.
  • Ischemia is a common cause of IUGR, stemming from inadequate capillary loop formation in terminal villi.

Purpose of the Study:

  • To review current data on placental angiogenesis changes in Intrauterine growth restriction (IUGR).
  • To elucidate the mechanisms of placental vascular supply development under physiological and IUGR conditions.

Main Methods:

  • This study is a review of existing literature.
  • Focuses on up-to-date data regarding placental angiogenesis and its role in IUGR.

Main Results:

  • Pathological changes in placental vascular development, particularly ischemia, are strongly linked to IUGR.
  • Insufficient capillary loop formation during villi development is a key factor in IUGR.
  • Understanding these mechanisms is crucial for identifying potential interventions.

Conclusions:

  • The review summarizes the mechanisms of placental vascularization in both normal and growth-restricted pregnancies.
  • Highlights the critical role of angiogenesis in fetal development and the consequences of its disruption in IUGR.
Abstract

Related Concept Videos

Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
2.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K